Back to Search
JOHN SARANTOPOULOS, M.D.
M.D.
Medical Oncology Physician
NPI: 1861495343IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
L8940(TX)
Education
OTHER
Class of 1997
Research & Publications (4)
Satraplatin, an oral platinum, administered on a five-day every-five-week schedule: a pharmacokinetic and food effect study.
PMID 19458055·Clin Cancer Res·2009
2-rct
Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies.
PMID 19034451·Cancer Chemother Pharmacol·2009
3-trial
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.
PMID 18795291·Cancer Chemother Pharmacol·2009
3-trial
A phase 1 open-label, accelerated dose-escalation study of the hypoxia-activated prodrug AQ4N in patients with advanced malignancies.
PMID 18981010·Clin Cancer Res·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7979 WURZBACH RD
SAN ANTONIO, TX 78229 - Phone
- (210) 450-1000
Quick Facts
- NPI
- 1861495343
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 4
Are you this provider?
Claim Your Profile